Polly A. Murphy's most recent trade in Atea Pharmaceuticals Inc was a trade of 41,200 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 41,200 | 41,200 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 29,600 | 29,600 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 29,600 | 0 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 29,600 | 86,045 | - | 0 | Common Stock | |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 14,048 | 14,048 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 16,300 | 16,300 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 16,300 | 0 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 11,645 | 11,645 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 11,645 | 0 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jun 2024 | 8,153 | 0 | - | - | Stock Option (right to buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 41,200 | 41,200 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 29,600 | 29,600 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 33,150 | 0 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 33,150 | 56,445 | - | 0 | Common Stock | |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 8,153 | 8,153 | - | - | Stock Option (right to buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 46,750 | 46,750 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 33,150 | 33,150 | - | - | Restricted Stock Units | |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 11,645 | 11,645 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Purchase of securities on an exchange or from another person at price $ 9.68 per share. | 22 Nov 2022 | 5,000 | 5,000 (0%) | 0% | 9.7 | 48,383 | Common Stock |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 16,300 | 16,300 | - | - | Stock Option (right to buy) | |
| Celcuity Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 61,264 | 61,264 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | 03 Nov 2020 | 11,295 | 11,295 | - | - | Common Stock | ||
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | 03 Nov 2020 | 7,122 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Atea Pharmaceuticals Inc | Polly A. Murphy | Director | 03 Nov 2020 | 4,173 | 0 | - | - | Series D-1 Convertible Preferred Stock |